Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom van der Poll

Showing results (1-10 of 774) with videos related to

Pageof 78
Sort By:
Critical Care (London, England)|April 23, 2016
Future of sepsis therapiesTom van der Poll
American Journal of Respiratory and Critical Care Medicine|August 2, 2017
Myeloid-derived Suppressor Cells in SepsisTom van der Poll
Blood|August 3, 2013
The endothelial protein C receptor and malariaTom van der Poll
Blood|May 14, 2011
Thrombin and diabetic nephropathyTom van der Poll
JAMA|May 20, 2019
Recombinant Human Soluble Thrombomodulin in Patients With Sepsis-Associated Coagulopathy: Another Negative Sepsis Trial?Tom van der Poll
Critical Care Medicine|February 19, 2014
Tumor necrosis factor inhibition in severe sepsis: a promise not fulfilled*Tom van der Poll
Critical Care (London, England)|December 25, 2008
Tissue factor as an initiator of coagulation and inflammation in the lungTom van der Poll
Critical Care Medicine|January 18, 2014
The remarkable career of leptin: from antidote to obesity to mediator of lung inflammationTom van der Poll
Surgical Infections|October 11, 2012
Preclinical sepsis modelsTom van der Poll
Critical Care (London, England)|March 18, 2009
Diabetes and sepsis outcomes--it is not all bad newsSachin Yende, Tom van der Poll
Pageof 78

Showing results (1-10 of 774) with videos related to

Sort By:
Pageof 78
Critical Care (London, England)|April 23, 2016
Future of sepsis therapiesTom van der Poll
American Journal of Respiratory and Critical Care Medicine|August 2, 2017
Myeloid-derived Suppressor Cells in SepsisTom van der Poll
Blood|August 3, 2013
The endothelial protein C receptor and malariaTom van der Poll
Blood|May 14, 2011
Thrombin and diabetic nephropathyTom van der Poll
JAMA|May 20, 2019
Recombinant Human Soluble Thrombomodulin in Patients With Sepsis-Associated Coagulopathy: Another Negative Sepsis Trial?Tom van der Poll
Critical Care Medicine|February 19, 2014
Tumor necrosis factor inhibition in severe sepsis: a promise not fulfilled*Tom van der Poll
Critical Care (London, England)|December 25, 2008
Tissue factor as an initiator of coagulation and inflammation in the lungTom van der Poll
Critical Care Medicine|January 18, 2014
The remarkable career of leptin: from antidote to obesity to mediator of lung inflammationTom van der Poll
Surgical Infections|October 11, 2012
Preclinical sepsis modelsTom van der Poll
Critical Care (London, England)|March 18, 2009
Diabetes and sepsis outcomes--it is not all bad newsSachin Yende, Tom van der Poll
Pageof 78